Joseph F. Dasta
University of Texas at Austin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph F. Dasta.
Critical Care Medicine | 2013
Juliana Barr; Gilles L. Fraser; Kathleen Puntillo; E. Wesley Ely; Céline Gélinas; Joseph F. Dasta; Judy E. Davidson; John W. Devlin; John P. Kress; Aaron M. Joffe; Douglas B. Coursin; Daniel L. Herr; Avery Tung; Bryce R.H. Robinson; Dorrie K. Fontaine; Michael A. E. Ramsay; Richard R. Riker; Curtis N. Sessler; Brenda T. Pun; Yoanna Skrobik; Roman Jaeschke
Objective:To revise the “Clinical Practice Guidelines for the Sustained Use of Sedatives and Analgesics in the Critically Ill Adult” published in Critical Care Medicine in 2002. Methods:The American College of Critical Care Medicine assembled a 20-person, multidisciplinary, multi-institutional task force with expertise in guideline development, pain, agitation and sedation, delirium management, and associated outcomes in adult critically ill patients. The task force, divided into four subcommittees, collaborated over 6 yr in person, via teleconferences, and via electronic communication. Subcommittees were responsible for developing relevant clinical questions, using the Grading of Recommendations Assessment, Development and Evaluation method (http://www.gradeworkinggroup.org) to review, evaluate, and summarize the literature, and to develop clinical statements (descriptive) and recommendations (actionable). With the help of a professional librarian and Refworks® database software, they developed a Web-based electronic database of over 19,000 references extracted from eight clinical search engines, related to pain and analgesia, agitation and sedation, delirium, and related clinical outcomes in adult ICU patients. The group also used psychometric analyses to evaluate and compare pain, agitation/sedation, and delirium assessment tools. All task force members were allowed to review the literature supporting each statement and recommendation and provided feedback to the subcommittees. Group consensus was achieved for all statements and recommendations using the nominal group technique and the modified Delphi method, with anonymous voting by all task force members using E-Survey (http://www.esurvey.com). All voting was completed in December 2010. Relevant studies published after this date and prior to publication of these guidelines were referenced in the text. The quality of evidence for each statement and recommendation was ranked as high (A), moderate (B), or low/very low (C). The strength of recommendations was ranked as strong (1) or weak (2), and either in favor of (+) or against (–) an intervention. A strong recommendation (either for or against) indicated that the intervention’s desirable effects either clearly outweighed its undesirable effects (risks, burdens, and costs) or it did not. For all strong recommendations, the phrase “We recommend …” is used throughout. A weak recommendation, either for or against an intervention, indicated that the trade-off between desirable and undesirable effects was less clear. For all weak recommendations, the phrase “We suggest …” is used throughout. In the absence of sufficient evidence, or when group consensus could not be achieved, no recommendation (0) was made. Consensus based on expert opinion was not used as a substitute for a lack of evidence. A consistent method for addressing potential conflict of interest was followed if task force members were coauthors of related research. The development of this guideline was independent of any industry funding. Conclusion:These guidelines provide a roadmap for developing integrated, evidence-based, and patient-centered protocols for preventing and treating pain, agitation, and delirium in critically ill patients.
Critical Care Medicine | 2005
Joseph F. Dasta; Trent P. McLaughlin; Samir H. Mody; Catherine Tak Piech
Objective:To quantify the mean daily cost of intensive care, identify key factors associated with increased cost, and determine the incremental cost of mechanical ventilation during a day in the intensive care unit. Design:Retrospective cohort analysis using data from NDCHealth’s Hospital Patient Level Database. Setting:A total of 253 geographically diverse U.S. hospitals. Patients:The study included 51,009 patients ≥18 yrs of age admitted to an intensive care unit between October 1, 2002, and December 31, 2002. Interventions:None. Measurements and Main Results:Days of intensive care and mechanical ventilation were identified using billing data, and daily costs were calculated as the sum of daily charges multiplied by hospital-specific cost-to-charge ratios. Cost data are presented as mean (±sd). Incremental daily cost of mechanical ventilation was calculated using log-linear regression, adjusting for patient and hospital characteristics. Approximately 36% of identified patients were mechanically ventilated at some point during their intensive care unit stay. Mechanically ventilated patients were older (63.5 yrs vs. 61.7 yrs, p < .0001) and more likely to be male (56.1% vs. 51.8%, p < 0.0001), compared with patients who were not mechanically ventilated, and required mechanical ventilation for a mean duration of 5.6 days ± 9.6. Mean intensive care unit cost and length of stay were
Critical Care Medicine | 2004
Steven M. Hollenberg; Tom Ahrens; Djillali Annane; Mark E. Astiz; Donald B. Chalfin; Joseph F. Dasta; Stephen O. Heard; Claude Martin; Lena M. Napolitano; Gregory M. Susla; Richard Totaro; Jean Louis Vincent; Sergio Zanotti-Cavazzoni
31,574 ± 42,570 and 14.4 days ± 15.8 for patients requiring mechanical ventilation and
Critical Care Medicine | 2001
Richard J. Brilli; Antoinette Spevetz; Richard D. Branson; Gladys M. Campbell; Henry Cohen; Joseph F. Dasta; Maureen A. Harvey; Mark A. Kelley; Kathleen Kelly; Maria I. Rudis; Arthur St. Andre; James R. Stone; Daniel Teres; Barry J. Weled
12,931 ± 20,569 and 8.5 days ± 10.5 for those not requiring mechanical ventilation. Daily costs were greatest on intensive care unit day 1 (mechanical ventilation,
Nephrology Dialysis Transplantation | 2008
Joseph F. Dasta; Sandra L. Kane-Gill; Amy J. Durtschi; Dev S. Pathak; John A. Kellum
10,794; no mechanical ventilation,
Annals of Pharmacotherapy | 2007
Anthony T. Gerlach; Joseph F. Dasta
6,667), decreased on day 2 (mechanical ventilation:,
Critical Care Medicine | 2013
Gilles L. Fraser; John W. Devlin; Craig P. Worby; Waleed Alhazzani; Juliana Barr; Joseph F. Dasta; John P. Kress; Judy E. Davidson; Frederick A. Spencer
4,796; no mechanical ventilation,
Critical Care Medicine | 1994
Sharon M. Watling; Joseph F. Dasta
3,496), and became stable after day 3 (mechanical ventilation,
Annals of Pharmacotherapy | 2009
Anthony T. Gerlach; Claire V. Murphy; Joseph F. Dasta
3,968; no mechanical ventilation,
Annals of Pharmacotherapy | 2010
Jay M. Mirtallo; Joseph F. Dasta; Kurt Kleinschmidt; Joseph Varon
3,184). Adjusting for patient and hospital characteristics, the mean incremental cost of mechanical ventilation in intensive care unit patients was